Cathie Wood’s ARK Invest ETFs (exchange-traded funds) reported several notable trades on Tuesday, September 16, 2025, ...

Flagship Pioneering’s Lila Sciences has landed a substantial $235 million series A as it looks to exceed the current limits ...

Shares of CRISPR Therapeutics CRSP have rallied 41.4% in the past three months, driven by encouraging data from a study of its in-vivo candidate, CTX310, as well as better-than-expected sales of ...

If you have been watching CRISPR Therapeutics (CRSP) lately, you have probably noticed the sharp rebound in its stock price. The rally was set off by compelling developments, specifically Casgevy’s ...

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...

Cathie Wood’s ARK ETFs have reported their daily trades for Tuesday, August 26th, 2025, with significant activity in biotech and tech stocks. The largest trade of the day was the purchase of 165,874 ...

While biotech hubs like Boston, San Francisco, San Diego and Raleigh-Durham, North Carolina, are home to thousands of ...

Government-funded academic research (GoFAR), lately the subject of across-the-board cuts in the U.S., is one of the engines ...

As the Digital Age evolves, savvy investors are turning to deep technologies like revolutionary materials and programmable ...

Nate Ennist of the Institute for Protein Design (IPD) at the University of Washington, in Seattle, thinks that synthetic ...